Tim Lohoff, PhD, will join the GeneNovate Investors' Day on 9 June in Berlin, participating as a panellist in the VC Panel 'Cell & Gene Therapy: The Investor Perspective' session at 11:40 AM CET.
Organised by the Berlin Institute of Health at Charité, the event convenes leading voices in cell and gene therapy to explore the science, investment landscape, and translational opportunities in the field.
GeneNovate Investors' Day offers a focused forum to discuss emerging trends and capital deployment strategies driving the next generation of cell and gene therapy innovation.